Detalhe da pesquisa
1.
A cohort study assessing the impact of small volume blood tubes on diagnostic test quality and iatrogenic blood loss in a cohort of adult haematology patients.
Intern Med J
; 48(7): 817-821, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363243
2.
The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma.
Eur J Haematol
; 94(4): 343-54, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25179233
3.
Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.
Haematologica
; 99(1): 163-71, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23935020
4.
Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma.
Br J Haematol
; 161(4): 499-507, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23438504
5.
Is serum ferritin a reliable indicator of iron status in elective major surgery patients?
Intern Med J
; 48(11): 1413, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30387304
6.
Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability.
Leukemia
; 33(2): 457-468, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30046162
7.
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution.
Leukemia
; 33(12): 2842-2853, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089247
8.
The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myeloma.
Leuk Res
; 39(3): 380-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25624048
9.
SAMSN1 is a tumor suppressor gene in multiple myeloma.
Neoplasia
; 16(7): 572-85, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117979
10.
Interleukin-3-mediated regulation of ß-catenin in myeloid transformation and acute myeloid leukemia.
J Leukoc Biol
; 96(1): 83-91, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24598054
11.
Assessment of whole body MRI and sestamibi technetium-99m bone marrow scan in prediction of multiple myeloma disease progression and outcome: a prospective comparative study.
BMJ Open
; 3(1)2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23315438